Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (331-340 of 370) with videos related to

Pageof 37
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2023
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individualsPamela C L Ferreira, Joseph Therriault, Cécile Tissot, et al.
Communications Medicine|November 20, 2025
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's diseaseLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
EMBO Molecular Medicine|October 10, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early ADMarcel S Woo, Joseph Therriault, Seyyed Ali Hosseini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Ebiomedicine|November 5, 2024
Identification of late-stage tau accumulation using plasma phospho-tau217Marcel S Woo, Joseph Therriault, Erin M Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 15, 2023
Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathologyBruna Bellaver, Albert Puig-Pijoan, João Pedro Ferrari-Souza, et al.
Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Tau profiling across Alzheimer's disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Tharick A Pascoal, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [<sup>18</sup>F]MK6240 Tau PET in Target RegionsCécile Tissot, Stijn Servaes, Firoza Z Lussier, et al.
Pageof 37

Showing results (331-340 of 370) with videos related to

Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 3, 2023
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individualsPamela C L Ferreira, Joseph Therriault, Cécile Tissot, et al.
Communications Medicine|November 20, 2025
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer's diseaseLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
EMBO Molecular Medicine|October 10, 2025
Glia inflammation and cell death pathways drive disease progression in preclinical and early ADMarcel S Woo, Joseph Therriault, Seyyed Ali Hosseini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Ebiomedicine|November 5, 2024
Identification of late-stage tau accumulation using plasma phospho-tau217Marcel S Woo, Joseph Therriault, Erin M Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 15, 2023
Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathologyBruna Bellaver, Albert Puig-Pijoan, João Pedro Ferrari-Souza, et al.
Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
Tau profiling across Alzheimer's disease staging reveals vulnerability to disease pathophysiologyGleb Bezgin, Tharick A Pascoal, Joseph Therriault, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [<sup>18</sup>F]MK6240 Tau PET in Target RegionsCécile Tissot, Stijn Servaes, Firoza Z Lussier, et al.
Pageof 37